Corrigendum: Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis

The authors wish to make the following corrections to their article: Sapin C, Hartry A, Kamat SA, Beillat M, Baker RA, Eramo A. Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis. Drugs in Context 201...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Just Medical Media Limited 2017
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499894/
https://www.ncbi.nlm.nih.gov/pubmed/28706556
http://dx.doi.org/10.7573/dic.212504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499894/
https://www.ncbi.nlm.nih.gov/pubmed/28706556
http://dx.doi.org/10.7573/dic.212504

Ejemplares similares